Dr.Evidence, a leading AI-enabled landscape intelligence platform, has announced significant enhancements designed to help life sciences enterprises accelerate their time-to-market for new drugs and indications. By integrating a comprehensive set of global content, Dr.Evidence provides the critical insights needed to navigate regulatory landscapes, reduce risks, and ensure successful paths to approval. Read More